| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | TRAIL receptor activity | 4.57e-07 | 4 | 98 | 3 | GO:0036463 | |
| GeneOntologyMolecularFunction | TRAIL binding | 1.14e-06 | 5 | 98 | 3 | GO:0045569 | |
| GeneOntologyMolecularFunction | death receptor activity | 3.06e-06 | 21 | 98 | 4 | GO:0005035 | |
| GeneOntologyMolecularFunction | tumor necrosis factor receptor activity | 2.44e-05 | 12 | 98 | 3 | GO:0005031 | |
| GeneOntologyMolecularFunction | zinc ion binding | EPRS1 TRAF6 SLC11A2 ZNF875 NSD1 GRIN2A GRIN2B ADAMTS5 TRIM64B EHMT2 MIB1 ADAMTS20 POLR1B NR5A1 | 1.12e-04 | 891 | 98 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | Toll-like receptor 2 binding | 1.42e-04 | 4 | 98 | 2 | GO:0035663 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activator activity involved in apoptotic process | 3.82e-04 | 29 | 98 | 3 | GO:0008656 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 4.93e-04 | 7 | 98 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | peptidase activator activity involved in apoptotic process | 5.13e-04 | 32 | 98 | 3 | GO:0016505 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 6.55e-04 | 8 | 98 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 6.55e-04 | 8 | 98 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 6.55e-04 | 8 | 98 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | lipopeptide binding | 1.05e-03 | 10 | 98 | 2 | GO:0071723 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.14e-03 | 93 | 98 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.31e-03 | 44 | 98 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.60e-03 | 102 | 98 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 1.80e-03 | 13 | 98 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | transition metal ion binding | EPRS1 TRAF6 SLC11A2 ZNF875 NSD1 GRIN2A GRIN2B ADAMTS5 TRIM64B EHMT2 MIB1 ADAMTS20 POLR1B NR5A1 | 1.96e-03 | 1189 | 98 | 14 | GO:0046914 |
| GeneOntologyMolecularFunction | glutamate binding | 2.09e-03 | 14 | 98 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase regulator activity involved in apoptotic process | 2.37e-03 | 54 | 98 | 3 | GO:0043028 | |
| GeneOntologyBiologicalProcess | activation of NF-kappaB-inducing kinase activity | 1.13e-06 | 17 | 99 | 4 | GO:0007250 | |
| GeneOntologyBiologicalProcess | TRAIL-activated apoptotic signaling pathway | 2.29e-05 | 12 | 99 | 3 | GO:0036462 | |
| GeneOntologyBiologicalProcess | activation-induced cell death of T cells | 4.68e-05 | 15 | 99 | 3 | GO:0006924 | |
| GeneOntologyBiologicalProcess | detection of bacterial lipopeptide | 6.82e-05 | 3 | 99 | 2 | GO:0070340 | |
| GeneOntologyBiologicalProcess | positive regulation of JUN kinase activity | 8.96e-05 | 49 | 99 | 4 | GO:0043507 | |
| GeneOntologyBiologicalProcess | detection of bacterial lipoprotein | 1.36e-04 | 4 | 99 | 2 | GO:0042494 | |
| GeneOntologyBiologicalProcess | Spemann organizer formation | 1.36e-04 | 4 | 99 | 2 | GO:0060061 | |
| MousePheno | abnormal midbrain-hindbrain boundary development | 8.82e-06 | 8 | 77 | 3 | MP:0004096 | |
| MousePheno | abnormal interleukin-12 secretion | 2.25e-05 | 62 | 77 | 5 | MP:0008662 | |
| MousePheno | abnormal operant conditioning behavior | 4.42e-05 | 13 | 77 | 3 | MP:0002803 | |
| MousePheno | decreased susceptibility to Herpesvirales infection induced morbidity/mortality | 5.60e-05 | 14 | 77 | 3 | MP:0031025 | |
| MousePheno | abnormal midbrain-hindbrain boundary morphology | 6.97e-05 | 15 | 77 | 3 | MP:0012132 | |
| MousePheno | decreased rhombomere 1 size | 8.95e-05 | 3 | 77 | 2 | MP:0012785 | |
| MousePheno | increased circulating interleukin-12b level | 1.24e-04 | 18 | 77 | 3 | MP:0008647 | |
| MousePheno | abnormal rhombomere 1 morphology | 1.78e-04 | 4 | 77 | 2 | MP:0012784 | |
| MousePheno | absent midbrain-hindbrain boundary | 1.78e-04 | 4 | 77 | 2 | MP:0012133 | |
| MousePheno | abnormal neuron number | 1.92e-04 | 456 | 77 | 10 | MP:0008946 | |
| MousePheno | decreased neuron number | 2.15e-04 | 376 | 77 | 9 | MP:0008948 | |
| MousePheno | decreased susceptibility to Herpesvirales infection | 2.29e-04 | 22 | 77 | 3 | MP:0020917 | |
| MousePheno | decreased cellular sensitivity to gamma-irradiation | 2.29e-04 | 22 | 77 | 3 | MP:0003207 | |
| MousePheno | abnormal embryonic neuroepithelium morphology | 2.80e-04 | 105 | 77 | 5 | MP:0004261 | |
| MousePheno | absent patella | 2.96e-04 | 5 | 77 | 2 | MP:0004694 | |
| MousePheno | decreased eye anterior chamber depth | 2.96e-04 | 5 | 77 | 2 | MP:0031212 | |
| Domain | TNFR_c6 | 7.94e-08 | 22 | 96 | 5 | PF00020 | |
| Domain | TNFR | 1.95e-07 | 26 | 96 | 5 | SM00208 | |
| Domain | TNFR_NGFR_1 | 3.48e-07 | 29 | 96 | 5 | PS00652 | |
| Domain | TNFR_NGFR_2 | 3.48e-07 | 29 | 96 | 5 | PS50050 | |
| Domain | FYVE | 3.48e-07 | 29 | 96 | 5 | PF01363 | |
| Domain | FYVE | 3.48e-07 | 29 | 96 | 5 | SM00064 | |
| Domain | TNFR_10 | 5.24e-07 | 4 | 96 | 3 | IPR020465 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 6.84e-07 | 33 | 96 | 5 | IPR001368 | |
| Domain | Znf_FYVE-rel | 7.99e-07 | 34 | 96 | 5 | IPR017455 | |
| Domain | Znf_FYVE | 1.42e-06 | 38 | 96 | 5 | IPR000306 | |
| Domain | ZF_FYVE | 1.84e-06 | 40 | 96 | 5 | PS50178 | |
| Domain | Znf_FYVE_PHD | 1.08e-05 | 147 | 96 | 7 | IPR011011 | |
| Domain | - | TRAF6 RAPSN PLEKHF1 NSD1 WDFY2 TRIM64B KMT2D MTMR4 MIB1 ZFYVE21 FGD1 | 1.93e-05 | 449 | 96 | 11 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | TRAF6 RAPSN PLEKHF1 NSD1 WDFY2 TRIM64B KMT2D MTMR4 MIB1 ZFYVE21 FGD1 | 2.36e-05 | 459 | 96 | 11 | IPR013083 |
| Domain | Post-SET_dom | 7.02e-05 | 16 | 96 | 3 | IPR003616 | |
| Domain | PostSET | 7.02e-05 | 16 | 96 | 3 | SM00508 | |
| Domain | POST_SET | 7.02e-05 | 16 | 96 | 3 | PS50868 | |
| Domain | NMDAR2_C | 7.82e-05 | 3 | 96 | 2 | PF10565 | |
| Domain | NMDAR2_C | 7.82e-05 | 3 | 96 | 2 | IPR018884 | |
| Domain | ADAM_spacer1 | 2.16e-04 | 23 | 96 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.16e-04 | 23 | 96 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.46e-04 | 24 | 96 | 3 | IPR013273 | |
| Domain | Toll-like_receptor | 2.59e-04 | 5 | 96 | 2 | IPR017241 | |
| Domain | PEROXIDASE_1 | 3.87e-04 | 6 | 96 | 2 | PS00435 | |
| Domain | Pep_M12B_propep | 1.05e-03 | 39 | 96 | 3 | PF01562 | |
| Domain | Peptidase_M12B_N | 1.05e-03 | 39 | 96 | 3 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 1.13e-03 | 40 | 96 | 3 | PS00427 | |
| Domain | Reprolysin | 1.13e-03 | 40 | 96 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 1.13e-03 | 40 | 96 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.13e-03 | 40 | 96 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 1.13e-03 | 40 | 96 | 3 | IPR001590 | |
| Domain | An_peroxidase | 1.15e-03 | 10 | 96 | 2 | PF03098 | |
| Domain | Haem_peroxidase_animal | 1.15e-03 | 10 | 96 | 2 | IPR019791 | |
| Domain | Haem_peroxidase | 1.15e-03 | 10 | 96 | 2 | IPR010255 | |
| Domain | PEROXIDASE_3 | 1.15e-03 | 10 | 96 | 2 | PS50292 | |
| Domain | - | 1.15e-03 | 10 | 96 | 2 | 1.10.640.10 | |
| Domain | SET | 1.22e-03 | 41 | 96 | 3 | PF00856 | |
| Domain | Disintegrin_dom | 1.22e-03 | 41 | 96 | 3 | IPR001762 | |
| Domain | Growth_fac_rcpt_ | 1.26e-03 | 156 | 96 | 5 | IPR009030 | |
| Domain | Frizzled | 1.40e-03 | 11 | 96 | 2 | IPR000539 | |
| Domain | Frizzled | 1.40e-03 | 11 | 96 | 2 | PF01534 | |
| Domain | Frizzled | 1.40e-03 | 11 | 96 | 2 | SM01330 | |
| Domain | SET | 1.70e-03 | 46 | 96 | 3 | SM00317 | |
| Domain | EGF-like_dom | 1.80e-03 | 249 | 96 | 6 | IPR000742 | |
| Domain | SET_dom | 2.17e-03 | 50 | 96 | 3 | IPR001214 | |
| Domain | SET | 2.17e-03 | 50 | 96 | 3 | PS50280 | |
| Domain | TIL_dom | 2.29e-03 | 14 | 96 | 2 | IPR002919 | |
| Domain | PLAC | 2.29e-03 | 14 | 96 | 2 | PF08686 | |
| Domain | VWF_type-D | 2.99e-03 | 16 | 96 | 2 | IPR001846 | |
| Domain | Laminin_N | 2.99e-03 | 16 | 96 | 2 | IPR008211 | |
| Domain | VWFD | 2.99e-03 | 16 | 96 | 2 | PS51233 | |
| Domain | LamNT | 2.99e-03 | 16 | 96 | 2 | SM00136 | |
| Domain | VWD | 2.99e-03 | 16 | 96 | 2 | SM00216 | |
| Domain | LAMININ_NTER | 2.99e-03 | 16 | 96 | 2 | PS51117 | |
| Domain | Laminin_N | 2.99e-03 | 16 | 96 | 2 | PF00055 | |
| Domain | VWD | 2.99e-03 | 16 | 96 | 2 | PF00094 | |
| Domain | Frizzled/SFRP | 2.99e-03 | 16 | 96 | 2 | IPR015526 | |
| Domain | aa-tRNA-synth_I_CS | 3.79e-03 | 18 | 96 | 2 | IPR001412 | |
| Domain | Lig_chan-Glu_bd | 3.79e-03 | 18 | 96 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 3.79e-03 | 18 | 96 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 3.79e-03 | 18 | 96 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 3.79e-03 | 18 | 96 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 3.79e-03 | 18 | 96 | 2 | IPR001508 | |
| Domain | Lig_chan | 3.79e-03 | 18 | 96 | 2 | PF00060 | |
| Domain | PBPe | 3.79e-03 | 18 | 96 | 2 | SM00079 | |
| Domain | TSP_1 | 4.18e-03 | 63 | 96 | 3 | PF00090 | |
| Domain | PLAC | 4.22e-03 | 19 | 96 | 2 | PS50900 | |
| Domain | PLAC | 4.22e-03 | 19 | 96 | 2 | IPR010909 | |
| Domain | AA_TRNA_LIGASE_I | 4.22e-03 | 19 | 96 | 2 | PS00178 | |
| Domain | TSP1 | 4.57e-03 | 65 | 96 | 3 | SM00209 | |
| Domain | TSP1_rpt | 4.57e-03 | 65 | 96 | 3 | IPR000884 | |
| Domain | TSP1 | 4.57e-03 | 65 | 96 | 3 | PS50092 | |
| Domain | FRI | 4.68e-03 | 20 | 96 | 2 | SM00063 | |
| Domain | RING | 4.90e-03 | 305 | 96 | 6 | SM00184 | |
| Pathway | REACTOME_TRAIL_SIGNALING | 7.95e-06 | 8 | 75 | 3 | MM15449 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS | 3.07e-05 | 12 | 75 | 3 | M27631 | |
| Pathway | REACTOME_REGULATION_BY_C_FLIP | 3.98e-05 | 13 | 75 | 3 | MM14947 | |
| Pathway | WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY | 1.11e-04 | 18 | 75 | 3 | M39478 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND | 1.32e-04 | 19 | 75 | 3 | MM14555 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY | 2.37e-04 | 23 | 75 | 3 | MM15176 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 2.76e-04 | 5 | 75 | 2 | M47667 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 4.13e-04 | 6 | 75 | 2 | M47668 | |
| Pathway | PID_TRAIL_PATHWAY | 4.31e-04 | 28 | 75 | 3 | M79 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 4.31e-04 | 28 | 75 | 3 | M77 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88 | 5.84e-04 | 31 | 75 | 3 | M39573 | |
| Pubmed | 1.45e-08 | 95 | 103 | 7 | 20568250 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 31473246 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 30423122 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 24117005 | ||
| Pubmed | Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy. | 1.01e-07 | 4 | 103 | 3 | 14769851 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 35103281 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 23584885 | ||
| Pubmed | The murine TRAIL receptor signals caspase-independent cell death through ceramide. | 1.01e-07 | 4 | 103 | 3 | 17026999 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 23815209 | ||
| Pubmed | Blockade of TRAIL pathway ameliorates HBV-induced hepatocyte apoptosis in an acute hepatitis model. | 1.01e-07 | 4 | 103 | 3 | 17126290 | |
| Pubmed | TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β. | 1.01e-07 | 4 | 103 | 3 | 36232931 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 24695582 | ||
| Pubmed | Activation of TRAIL-DR5 pathway promotes sensorineural degeneration in the inner ear. | 1.01e-07 | 4 | 103 | 3 | 26791792 | |
| Pubmed | TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis. | 1.01e-07 | 4 | 103 | 3 | 18079962 | |
| Pubmed | TRAIL-R as a negative regulator of innate immune cell responses. | 1.01e-07 | 4 | 103 | 3 | 15589175 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 23605004 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 38199990 | ||
| Pubmed | TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL. | 1.01e-07 | 4 | 103 | 3 | 15921376 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 35264458 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 22916132 | ||
| Pubmed | Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity. | 1.01e-07 | 4 | 103 | 3 | 23676461 | |
| Pubmed | Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis. | 1.01e-07 | 4 | 103 | 3 | 24994655 | |
| Pubmed | DR5 knockout mice are compromised in radiation-induced apoptosis. | 1.01e-07 | 4 | 103 | 3 | 15713653 | |
| Pubmed | The TNF and TNF receptor superfamilies: integrating mammalian biology. | 1.10e-07 | 39 | 103 | 5 | 11239407 | |
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 23347256 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 23071253 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 20807702 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 19349211 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 36791922 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 15173180 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 21225479 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 12808117 | ||
| Pubmed | Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells. | 2.51e-07 | 5 | 103 | 3 | 21169546 | |
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 29403497 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 11844843 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 18079967 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 10862756 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 24466325 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 30850660 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 10383128 | ||
| Pubmed | TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction. | 2.51e-07 | 5 | 103 | 3 | 12488957 | |
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 17051329 | ||
| Pubmed | TRAIL induces proliferation in rodent pancreatic beta cells via AKT activation. | 2.51e-07 | 5 | 103 | 3 | 33875613 | |
| Pubmed | Expression of TRAIL and its receptors DR5 and DcR2 in orthodontic tooth movement. | 2.51e-07 | 5 | 103 | 3 | 23430714 | |
| Pubmed | TRAIL and KILLER are expressed and induce apoptosis in the murine preimplantation embryo. | 2.51e-07 | 5 | 103 | 3 | 15128592 | |
| Pubmed | Following a TRAIL: update on a ligand and its five receptors. | 2.51e-07 | 5 | 103 | 3 | 15538968 | |
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 28444885 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 22789540 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 17041756 | ||
| Pubmed | Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. | 2.51e-07 | 5 | 103 | 3 | 19226377 | |
| Pubmed | CD8 T cells utilize TRAIL to control influenza virus infection. | 2.51e-07 | 5 | 103 | 3 | 18802095 | |
| Pubmed | Death receptor 5 signaling promotes hepatocyte lipoapoptosis. | 2.51e-07 | 5 | 103 | 3 | 21941003 | |
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 11029007 | ||
| Pubmed | A renal YY1-KIM1-DR5 axis regulates the progression of acute kidney injury. | 5.01e-07 | 6 | 103 | 3 | 37460623 | |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 21832159 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 18006832 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 28055006 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 16174727 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 16046522 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 15990565 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 18192669 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 15514675 | ||
| Pubmed | Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. | 5.01e-07 | 6 | 103 | 3 | 18667695 | |
| Pubmed | 5.09e-07 | 22 | 103 | 4 | 15301860 | ||
| Pubmed | Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2. | 8.75e-07 | 7 | 103 | 3 | 34223817 | |
| Pubmed | Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. | 8.75e-07 | 7 | 103 | 3 | 9192640 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 21938487 | ||
| Pubmed | Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. | 8.75e-07 | 7 | 103 | 3 | 11265645 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 22833210 | ||
| Pubmed | Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. | 1.23e-06 | 263 | 103 | 8 | 19773279 | |
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 26991125 | ||
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 25843002 | ||
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 15044455 | ||
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 26609054 | ||
| Pubmed | 2.09e-06 | 9 | 103 | 3 | 17617585 | ||
| Pubmed | 2.98e-06 | 10 | 103 | 3 | 24971483 | ||
| Pubmed | 2.98e-06 | 10 | 103 | 3 | 21768400 | ||
| Pubmed | 2.98e-06 | 10 | 103 | 3 | 22013112 | ||
| Pubmed | 4.09e-06 | 11 | 103 | 3 | 30988397 | ||
| Pubmed | 4.09e-06 | 11 | 103 | 3 | 17582687 | ||
| Pubmed | Common genetic variants in candidate genes and risk of familial lymphoid malignancies. | 4.85e-06 | 145 | 103 | 6 | 19573080 | |
| Pubmed | LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L. | 5.44e-06 | 12 | 103 | 3 | 30254289 | |
| Pubmed | Polymorphisms in interleukin-1 receptor-associated kinase 4 are associated with total serum IgE. | 5.44e-06 | 12 | 103 | 3 | 19254290 | |
| Pubmed | Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential. | 5.44e-06 | 12 | 103 | 3 | 29436413 | |
| Pubmed | 7.06e-06 | 13 | 103 | 3 | 26982364 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22315281 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25131300 | ||
| Pubmed | Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. | 8.69e-06 | 2 | 103 | 2 | 18036178 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 37657442 | ||
| Pubmed | TRAIL induces death of human oligodendrocytes isolated from adult brain. | 8.69e-06 | 2 | 103 | 2 | 12390973 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 38813758 | ||
| Pubmed | Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease. | 8.69e-06 | 2 | 103 | 2 | 38731978 | |
| Pubmed | Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. | 8.69e-06 | 2 | 103 | 2 | 20921396 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24445834 | ||
| Pubmed | A genomic reservoir for Tnfrsf genes is developmentally regulated and imprinted in the mouse. | 8.69e-06 | 2 | 103 | 2 | 22595876 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 26470427 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 33443215 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 30269991 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27199241 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24649804 | ||
| Interaction | IGFL3 interactions | 1.64e-06 | 75 | 97 | 6 | int:IGFL3 | |
| Interaction | LRP6 interactions | 2.83e-06 | 128 | 97 | 7 | int:LRP6 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 2.52e-04 | 135 | 103 | 4 | chr8p21 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.63e-07 | 29 | 80 | 5 | 782 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 2.32e-07 | 31 | 80 | 5 | 81 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 7.68e-05 | 19 | 80 | 3 | 50 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 4.00e-04 | 7 | 80 | 2 | 1201 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.52e-04 | 34 | 80 | 3 | 487 | |
| GeneFamily | CD molecules|Toll like receptors | 8.50e-04 | 10 | 80 | 2 | 948 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.04e-03 | 11 | 80 | 2 | 286 | |
| GeneFamily | Low density lipoprotein receptors | 1.46e-03 | 13 | 80 | 2 | 634 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.79e-03 | 394 | 80 | 7 | 471 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 3.15e-03 | 19 | 80 | 2 | 131 | |
| GeneFamily | Regulators of G-protein signaling | 3.84e-03 | 21 | 80 | 2 | 720 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 5.01e-03 | 24 | 80 | 2 | 76 | |
| GeneFamily | ArfGAPs | 9.34e-03 | 33 | 80 | 2 | 395 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 103 | 6 | 4d04df9776394ea156ed5822f92ae74fdefbaa3d | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 103 | 6 | 3acf35b774ebc0f9e96299d0bd3e9d03bbf6b90c | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.32e-06 | 175 | 103 | 6 | 3bdccb4037053795d62ab5b6fcc09cdd406f9b50 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.32e-06 | 175 | 103 | 6 | 770546ddaa49ee482c4c7577ab76efbc6c304a29 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.79e-06 | 179 | 103 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.72e-06 | 186 | 103 | 6 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.15e-06 | 200 | 103 | 6 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.15e-06 | 200 | 103 | 6 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.15e-06 | 200 | 103 | 6 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6-Slc17a7.Nr4a2_(Claustrum)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.24e-05 | 78 | 103 | 4 | 564ea2c113058df595c3b69827cf9a72380b48fc | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6-Slc17a7.Nr4a2_(Claustrum)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.24e-05 | 78 | 103 | 4 | dfe16ac0b10dce7ecf4b3a0b4e1013ac58cb9fc1 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6-Slc17a7.Nr4a2_(Claustrum)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.24e-05 | 78 | 103 | 4 | 6aa418ea30dfa7df2fc08cac5b31e3a654aaa7f0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 164 | 103 | 5 | 83141be8dfed85511ea6afda7c76ff4b6b5ef021 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 168 | 103 | 5 | 04a7810f95196a21325356b42084f96c11af5964 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 169 | 103 | 5 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 169 | 103 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.71e-05 | 177 | 103 | 5 | 6f3b254e56e722cc23495b49e99a4abce0243cb3 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-05 | 178 | 103 | 5 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.02e-05 | 179 | 103 | 5 | c815eb9f760fe4ca7a5e49beb224659f0b864f22 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.02e-05 | 179 | 103 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 180 | 103 | 5 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.18e-05 | 180 | 103 | 5 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.18e-05 | 180 | 103 | 5 | f103e161e966c257eac97e1b30a461c4ed9cafc2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.34e-05 | 181 | 103 | 5 | c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.51e-05 | 182 | 103 | 5 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-05 | 184 | 103 | 5 | ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 186 | 103 | 5 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 186 | 103 | 5 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.40e-05 | 187 | 103 | 5 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.40e-05 | 187 | 103 | 5 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.40e-05 | 187 | 103 | 5 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 7.59e-05 | 188 | 103 | 5 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.59e-05 | 188 | 103 | 5 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.59e-05 | 188 | 103 | 5 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.78e-05 | 189 | 103 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 190 | 103 | 5 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.98e-05 | 190 | 103 | 5 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.18e-05 | 191 | 103 | 5 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.38e-05 | 192 | 103 | 5 | 93903576dddd8227328e4ced75aa7625eedb9baf | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.38e-05 | 192 | 103 | 5 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.59e-05 | 193 | 103 | 5 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.80e-05 | 194 | 103 | 5 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.80e-05 | 194 | 103 | 5 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.01e-05 | 195 | 103 | 5 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.23e-05 | 196 | 103 | 5 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.46e-05 | 197 | 103 | 5 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-05 | 197 | 103 | 5 | 61bda9b5102fdbce902bb976d1aa62f2c799d2fb | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.46e-05 | 197 | 103 | 5 | 6852a8ec1397811bbdd1fc625c52ed4fa75a931e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.46e-05 | 197 | 103 | 5 | 2f91b3870a7058168093a143110954c07588cfe9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.46e-05 | 197 | 103 | 5 | d2a4d7e92e91bcc47a7657da2e5c8a3ad7eb08ad | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.69e-05 | 198 | 103 | 5 | 19eefd05573fbaed654af52bf0f8a26092b8b229 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.69e-05 | 198 | 103 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_only / Treatment groups by lineage, cell group, cell type | 9.69e-05 | 198 | 103 | 5 | 53c22e81e530d6fc272d4a45c8d1bf125feb254d | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.69e-05 | 198 | 103 | 5 | de5748c2b66ecc432974cf095ecd241369579f7c | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | 514dbf128b6832b1cbd65be023d4fe02400e8dec | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | 6dc446a5d183b01bdf227e45bd88d0b3d8b1c56a | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 9.92e-05 | 199 | 103 | 5 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | distal-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.92e-05 | 199 | 103 | 5 | 21b44031bc5182ee23ba5e206042b2e5e4ee0c3c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 103 | 5 | 4db894cfb80fd1f9e01133f345eefd78edd4bc43 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 103 | 5 | d46a19274c2836ce7494790ce513764dedcadc79 | |
| ToppCell | Kidney-Fibroblasts|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.02e-04 | 200 | 103 | 5 | 2c265ad8314a21bce50ac21b16da2fea125366ea | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 105 | 103 | 4 | 8f31edf4183587f5b53941475453c5aa49f10bbd | |
| Disease | osteoarthritis (biomarker_via_orthology) | 6.56e-07 | 21 | 98 | 4 | DOID:8398 (biomarker_via_orthology) | |
| Disease | Profound Mental Retardation | 7.23e-06 | 139 | 98 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 7.23e-06 | 139 | 98 | 6 | C0025363 | |
| Disease | Mental deficiency | 7.23e-06 | 139 | 98 | 6 | C0917816 | |
| Disease | Intellectual Disability | 1.85e-05 | 447 | 98 | 9 | C3714756 | |
| Disease | Cluttering | 3.27e-05 | 3 | 98 | 2 | C0009090 | |
| Disease | Dyslalia | 3.27e-05 | 3 | 98 | 2 | C3495145 | |
| Disease | Aprosodia | 3.27e-05 | 3 | 98 | 2 | C0233726 | |
| Disease | Rhinolalia | 3.27e-05 | 3 | 98 | 2 | C0751513 | |
| Disease | Dysglossia | 3.27e-05 | 3 | 98 | 2 | C0751512 | |
| Disease | Verbal Fluency Disorders | 3.27e-05 | 3 | 98 | 2 | C0751514 | |
| Disease | neck circumference | 3.31e-05 | 19 | 98 | 3 | EFO_0011043 | |
| Disease | Huntington's disease (is_implicated_in) | 5.99e-05 | 23 | 98 | 3 | DOID:12858 (is_implicated_in) | |
| Disease | Speech Disorders | 6.52e-05 | 4 | 98 | 2 | C0037822 | |
| Disease | neutrophil count, basophil count | 1.05e-04 | 224 | 98 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | cone-rod dystrophy (is_implicated_in) | 1.08e-04 | 5 | 98 | 2 | DOID:0050572 (is_implicated_in) | |
| Disease | tuberculosis (is_implicated_in) | 1.10e-04 | 28 | 98 | 3 | DOID:399 (is_implicated_in) | |
| Disease | 1-stearoyl-GPC (18:0) measurement | 1.62e-04 | 6 | 98 | 2 | EFO_0800217 | |
| Disease | colon cancer (biomarker_via_orthology) | 2.98e-04 | 39 | 98 | 3 | DOID:219 (biomarker_via_orthology) | |
| Disease | placental insufficiency (biomarker_via_orthology) | 3.02e-04 | 8 | 98 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 3.02e-04 | 8 | 98 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | aspergillosis (is_implicated_in) | 3.02e-04 | 8 | 98 | 2 | DOID:13564 (is_implicated_in) | |
| Disease | 22q11 partial monosomy syndrome | 3.87e-04 | 9 | 98 | 2 | C3266101 | |
| Disease | Asymmetric crying face association | 4.83e-04 | 10 | 98 | 2 | C0431406 | |
| Disease | phosphatidylethanolamine ether measurement | 4.83e-04 | 10 | 98 | 2 | EFO_0010229 | |
| Disease | 22q11 Deletion Syndrome | 4.83e-04 | 10 | 98 | 2 | C2936346 | |
| Disease | Epilepsy | 4.87e-04 | 109 | 98 | 4 | C0014544 | |
| Disease | complement factor H-related protein 4 measurement | 5.86e-04 | 49 | 98 | 3 | EFO_0600091 | |
| Disease | Microphthalmos | 5.89e-04 | 11 | 98 | 2 | C0026010 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 5.89e-04 | 11 | 98 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | vascular dementia (is_marker_for) | 5.89e-04 | 11 | 98 | 2 | DOID:8725 (is_marker_for) | |
| Disease | neutrophil count, eosinophil count | 7.37e-04 | 213 | 98 | 5 | EFO_0004833, EFO_0004842 | |
| Disease | male infertility (implicated_via_orthology) | 8.32e-04 | 13 | 98 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | myeloid white cell count | CCDC125 MPO ZDHHC18 RAPSN TNFRSF10C RREB1 GALNT17 PTPRJ POLR1B LTBR | 1.12e-03 | 937 | 98 | 10 | EFO_0007988 |
| Disease | DiGeorge Syndrome | 1.27e-03 | 16 | 98 | 2 | C0012236 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 1.27e-03 | 16 | 98 | 2 | C0795907 | |
| Disease | phosphatidylcholine 32:2 measurement | 1.27e-03 | 16 | 98 | 2 | EFO_0010374 | |
| Disease | Shprintzen syndrome | 1.27e-03 | 16 | 98 | 2 | C0220704 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 1.44e-03 | 17 | 98 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | intraocular pressure measurement | 1.56e-03 | 509 | 98 | 7 | EFO_0004695 | |
| Disease | granulocyte count | 1.61e-03 | 254 | 98 | 5 | EFO_0007987 | |
| Disease | anorexia nervosa | 1.66e-03 | 70 | 98 | 3 | MONDO_0005351 | |
| Disease | hepatitis B virus infection | 1.80e-03 | 19 | 98 | 2 | EFO_0004197 | |
| Disease | Ovarian Failure, Premature | 2.20e-03 | 21 | 98 | 2 | C0085215 | |
| Disease | myeloperoxidase (MPO)-DNA complex measurement | 2.42e-03 | 22 | 98 | 2 | EFO_0011039 | |
| Disease | Attention Deficit Disorder | 2.42e-03 | 22 | 98 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 2.42e-03 | 22 | 98 | 2 | C1321905 | |
| Disease | nephrosis (biomarker_via_orthology) | 2.42e-03 | 22 | 98 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 2.60e-03 | 82 | 98 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.60e-03 | 82 | 98 | 3 | C0751111 | |
| Disease | Aura | 2.60e-03 | 82 | 98 | 3 | C0236018 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.87e-03 | 24 | 98 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | Attention deficit hyperactivity disorder | 2.87e-03 | 24 | 98 | 2 | C1263846 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.87e-03 | 24 | 98 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | Kidney Diseases | 3.18e-03 | 88 | 98 | 3 | C0022658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VDSKSMQVPFSRCCF | 21 | P22362 | |
| PQGMEIKSNERCCSF | 261 | O95394 | |
| CTGKRAIYRSCSLMP | 606 | Q9UNA0 | |
| AFDMIGQRSRSSKCP | 196 | Q8TF64 | |
| MSRKGPRAEVCADCS | 1 | Q9Y2X7 | |
| TERGFEELPLCSCRM | 416 | Q96KQ7 | |
| RRFCFEVVSPTKSCM | 326 | Q15057 | |
| SGRSPQECCLRVSLM | 1691 | Q96BY7 | |
| PISGMCSKYRSCTIN | 406 | Q8TE57 | |
| VGRRMKFRSCNTDSC | 596 | P59510 | |
| MPRGKFICNECRTGI | 1576 | Q96L73 | |
| VSASKGRLMRCVRCP | 1651 | Q96L73 | |
| TRSCPNCRRSSMKPG | 396 | Q13702 | |
| SDASCMSQRRPKCRA | 141 | Q9H2L5 | |
| VPGCVNTTEMDIRKC | 206 | P49758 | |
| CCPQGFLRSGTKRVM | 191 | Q8N7Y1 | |
| EKSCGACLREETPRM | 251 | Q8IYF1 | |
| VSCGKMAAPTRNTCT | 796 | Q12913 | |
| TMCQKEEFPCSRNGV | 411 | Q9Y561 | |
| CNCSRRGTIEAAMPE | 1356 | Q16787 | |
| DMACAKTTTRGECPR | 521 | Q6ZRS4 | |
| CPMTRIFDDGRCVSN | 906 | Q92824 | |
| TCPEQDKYRTITGMC | 166 | P05164 | |
| CSMFLCRSRNGIPEV | 96 | P51160 | |
| GRTEVMQKTCSCRFL | 56 | Q9UQ05 | |
| VLKGMFVPSCSGCRT | 236 | P49281 | |
| SCRPGYKLMSDKRTC | 3136 | P98164 | |
| SQMGKPVSFSTFRRC | 36 | Q86WI0 | |
| MCLATCTRDGKPSAR | 81 | Q9NVS9 | |
| MRSPEGRQKAFSTCA | 226 | Q96R08 | |
| CRMNRKQYIRSCPGT | 551 | C9JSJ3 | |
| MAQKEGGRTVPCCSR | 1 | P05981 | |
| GCCSKRPNSKQMRAT | 931 | Q9NYA4 | |
| RRVPFIMCCGGKSSE | 906 | Q86YT6 | |
| RGCSQPERVKFTLNM | 471 | Q8NA29 | |
| CISLRTFVMRNCAGP | 231 | Q6PIJ6 | |
| RSVCERAKAGCSPLM | 106 | Q13467 | |
| GCQCRAPMVSVSSER | 231 | Q9H461 | |
| LCMSPVGEAFRSRCR | 2576 | Q9C0G6 | |
| RSRCRMFPSLVNCCT | 2586 | Q9C0G6 | |
| GNPCSCARMAASTRK | 286 | Q86Z20 | |
| CSQPRENGMRSCRSV | 271 | O43497 | |
| RRAPGCAGRCITMKN | 71 | A8K010 | |
| SFSCAKRALMRRPGC | 121 | A0A1W2PPK0 | |
| GPGMSREQRRSCDCK | 1321 | Q5JV73 | |
| GHKPFQCRICMRSFS | 301 | Q06889 | |
| RTPAMIGCSFVVNRK | 321 | Q6IS24 | |
| ACEKRMLSVFSTCGR | 751 | P54198 | |
| EFQTELKCMCRPGFT | 1276 | P82279 | |
| EMRSCKPLTRESGCS | 231 | Q6ZVF9 | |
| FKPCFMGERSEIQCI | 421 | Q6ZTR5 | |
| SMRCYRKACRSASPS | 1401 | Q5VV67 | |
| SCLMAPSVSCRKRYS | 356 | Q5TDP6 | |
| GSCFSKRSCSVPEGM | 176 | Q13253 | |
| ATTDCSPCLRMVSNR | 2301 | Q6ZRI0 | |
| SPCLRMVSNRTFSAC | 2306 | Q6ZRI0 | |
| PDKATDICMRCTQTR | 151 | Q96S99 | |
| PFCRFQKCLTVGMRL | 66 | Q13285 | |
| SNNGCMRDPTLYRCK | 346 | P07814 | |
| LTCMSCTFRPGGAVR | 336 | Q7Z736 | |
| CPRCKGAAKRETDTM | 506 | Q15031 | |
| VSSRCEKACNPRMGN | 26 | Q9HB63 | |
| MPSKFSCRQLREAGQ | 1 | Q9HCE1 | |
| SLFTRMFCCKSCPNI | 721 | Q6P1X5 | |
| QPSRTCLGCFMESKD | 141 | Q5QGS0 | |
| CMRCQEPFNSITKRR | 736 | P98174 | |
| MTDCRLTSGKYPQCR | 101 | Q93091 | |
| MRSIKAGDNPFQCTC | 516 | Q15399 | |
| SFFCRMKCNRPSVKV | 246 | O00327 | |
| SKNSSRLGGRPCMCT | 36 | Q9H7T3 | |
| VGSSCKRPTVCMGRQ | 56 | B7Z368 | |
| FQDKNSPEMCRTCRT | 146 | Q9UBN6 | |
| RTCRTGCPRGMVKVS | 156 | Q9UBN6 | |
| KRRCTRFCSASLEMP | 236 | Q9Y2B4 | |
| TGRRFQKSICDPTCM | 1481 | Q8N2E2 | |
| KLPGRNTFCCDGRVM | 16 | Q9Y397 | |
| CSCMSFNPETRRLSI | 71 | Q96P53 | |
| MRSHTGERPYKCQTC | 1531 | Q92766 | |
| SNLSARSCRFCVMSP | 6 | P0C7P2 | |
| SRACSGPFMEQRRSK | 406 | Q6ZMY3 | |
| PCTFSTFGCHEKMQR | 241 | Q9Y4K3 | |
| SGARCMFFVRSSPVC | 871 | Q92626 | |
| FRNENSPEMCRKCSR | 116 | O14798 | |
| MCRTLAAFPTTCLER | 1 | O15492 | |
| KPGTFRNDNSAEMCR | 191 | O00220 | |
| MRSIKAGDNPFQCTC | 521 | Q9Y2C9 | |
| CRPGNGMVSRCSRSQ | 46 | P43489 | |
| TSCCERGFKAMNRIR | 1036 | O60290 | |
| CTSKRKTQCRCQPGM | 116 | P36941 | |
| GRTTVFSEMRQECKC | 206 | P04628 | |
| TRGPCPDMQSRCQTK | 71 | Q6PG37 | |
| RCCSQKVPLRRMCFV | 76 | Q9BQ24 | |
| PLHRCRCGKTFSNMT | 386 | Q8TF50 | |
| THSGEKPFMCRECGR | 546 | P10072 | |
| RVTKTVRPFSMVCCP | 351 | Q9BZH6 | |
| RRESPTMTEFLCKEC | 241 | Q9NUQ2 | |
| SGKFKCVCITMRVPR | 861 | Q9H9Y6 | |
| RGERPFTCMECGKSF | 541 | Q9ULD5 | |
| RALEMCPSCFQKERS | 141 | Q99614 | |
| GRAPMRCPSCRKTSE | 46 | A6NI03 | |
| ANAKGMCFIRTTRPE | 436 | P51854 | |
| TCKMFRPPRTSHCSV | 196 | Q9NUE0 | |
| AIKCTMCRAQRPSGT | 21 | Q9UGI0 | |
| KRQMFSLCGTTVPDC | 256 | Q2WGJ6 | |
| QRTGATSSCNRMRCP | 5096 | O14686 | |
| ERCFPRGQTDCAKML | 11 | O60663 | |
| RSPFKCDACLRMGNL | 1231 | Q12879 | |
| SGTCMRNTVPCQKRI | 426 | Q13224 |